| # | Drug | Count |
|---|---|---|
| 0 | PAZOPANIB HYDROCHLORIDE | 48 |
| 1 | DOXORUBICIN | 47 |
| 2 | TEMOZOLOMIDE | 47 |
| 3 | CYCLOPHOSPHAMIDE | 41 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 41 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 41 |
| 6 | IFOSFAMIDE | 41 |
| 7 | IFOSFAMIDE FOR INJECTION | 41 |
| 8 | TOPOTECAN | 40 |
| 9 | GEMCITABINE HYDROCHLORIDE | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN | 40 | 0.0065 |
| 1 | DACTINOMYCIN | 12 | 0.0054 |
| 2 | VINORELBINE | 33 | 0.0047 |
| 3 | LAROTRECTINIB | 3 | 0.0033 |
| 4 | TRABECTEDIN | 7 | 0.0030 |
| 5 | TEMOZOLOMIDE | 47 | 0.0022 |
| 6 | IFOSFAMIDE FOR INJECTION | 41 | 0.0019 |
| 7 | PAZOPANIB HYDROCHLORIDE | 48 | 0.0018 |
| 8 | IRINOTECAN HYDROCHLORIDE | 21 | 0.0016 |
| 9 | GEMCITABINE HYDROCHLORIDE | 38 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 62 |
| 1 | Topoisomerase Inhibitor [EPC] | 49 |
| 2 | Kinase Inhibitor [EPC] | 42 |
| 3 | Microtubule Inhibitor [EPC] | 37 |
| 4 | Serotonin-3 Receptor Antagonist [EPC] | 31 |
| 5 | Actinomycin [EPC] | 12 |
| 6 | Platinum-based Drug [EPC] | 11 |
| 7 | Leukocyte Growth Factor [EPC] | 5 |
| 8 | Corticosteroid [EPC] | 4 |
| 9 | Interleukin-2 Receptor Blocking Antibody [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 12 | 0.0054 |
| 1 | Topoisomerase Inhibitor [EPC] | 49 | 0.0006 |
| 2 | Alkylating Drug [EPC] | 62 | 0.0003 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 31 | 0.0002 |
| 4 | Microtubule Inhibitor [EPC] | 37 | 0.0002 |
| 5 | Kinase Inhibitor [EPC] | 42 | 0.0001 |
| 6 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 5 | 0.0000 |